Compare ACADIA Pharmaceuticals Inc. (ACAD) vs United States Brent Oil Fund LP (BNO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs United States Brent Oil Fund LP — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.45 (market cap $5.07B), while United States Brent Oil Fund LP trades at $51.08. The key difference: ACADIA Pharmaceuticals Inc. is trading nearer its 52-week high, United States Brent Oil Fund LP nearer its low. Which is the better fit depends on your goals.
| ACAD | BNO | |
|---|---|---|
Market Cap | $5.07B | — |
Sector | Health | Commodities - Energy |
52-Week High | $29.41 | $60.13 |
52-Week Low | $20.06 | $27.20 |
Enterprise Value | $4.19B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
BNO, a US-listed exchange-traded product tracking Brent crude oil futures, trades at $46.93, down 0.93% amid bearish technical signals. The overall technical outlook is bearish, with moving averages indicating selling pressure, while oscillators remain neutral. Recent news highlights Middle East tensions, particularly the deadlock over the Strait of Hormuz, influencing oil price volatility and investor sentiment.
The outlook for BNO is heavily tied to geopolitical developments and oil supply dynamics. Risks include prolonged Middle East instability and oil price corrections, but potential supply disruptions could offer upside. Investors should monitor OPEC decisions and US-Iran negotiations for directional cues, as these factors drive near-term performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About United States Brent Oil Fund LP
BNO is a commodity ETF that tracks the daily price of Brent crude oil futures. It provides exposure to the international oil benchmark, which often trades at a premium to the U.S. WTI benchmark, and is primarily used for short-term trading due to roll costs.
Read more on BNO →
